OTC

Strength

4; 200; 10 mg/1; mg/1; mg/1

NDC

00573019610

Classification

Brand

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

5/20/2015

Approval Type

New Drug (NDA)

FDA Application

NDA022113

On Market Since

7/23/2012

Pharmacological Classes

Adrenergic alpha1-Agonists
Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Nonsteroidal Anti-inflammatory Drug
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+0.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.